First experience with BCG discontinuation in Europe. BCG vaccination and HIV infection.
ten Dam
H G
HG
Division of Contageious Diseases, WHO, Geneva, Switzerland.
D000328:Adult; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D014376:Tuberculosis / Q000150:complications / Q000517:prevention & control*
D001500:BCG Vaccine